Network origin in Jamie Austin first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jamie Austin via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | General Counsel | |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel | |
| ANIKA THERAPEUTICS, INC. | Medical Specialties | Chief Operating Officer | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Portfolio Manager-Equities | |
| ACUSPHERE, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| CATALYST PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| GLAUKOS CORPORATION | Medical Specialties | Director/Board Member | |
Cerapedics, Inc.
 Cerapedics, Inc. Pharmaceuticals: MajorHealth Technology Cerapedics, Inc. engaged in the provision of developing and commercializing novel osteobiologic products. It offers i-FACTOR Bone Graft, an advanced biologic that supported with level I evidence, and provides benefit ratio. The company was founded by Andrew J. Tofe and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
| SONENDO, INC. | Medical Specialties | Director/Board Member | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Boston University | College/University | Undergraduate Degree | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Goodwin Procter LLP is a law firm which provides advice to companies in public and private enterprises. It provides services to financial, life sciences, private equity, real estate, and technolgy industries. The company was founded in 1912 and is headquartered in Boston, MA. | Investment Managers | Corporate Officer/Principal | |
| MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Yale University | College/University | Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree | |
| Vassar College | College/University | Undergraduate Degree | |
| Leeds Beckett University | College/University | Undergraduate Degree | |
| The Medical College of Wisconsin, Inc. | College/University | Doctorate Degree | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
| Hoechst Pharmaceuticals Ltd. | Chief Tech/Sci/R&D Officer | ||
| Biogen SA | General Counsel | ||
Arius, Inc.
 Arius, Inc. Engineering & ConstructionIndustrial Services Arius, Inc. manufactures electrical testing equipment. The company was founded in 1999 and is headquartered in Frederick, MD. | Engineering & Construction | Director/Board Member | |
| OTONOMY | Biotechnology | Director/Board Member | |
Rempex Pharmaceuticals, Inc.
 Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin | |
| Harvard Law School | College/University | Graduate Degree | |
| Yale School of Medicine | College/University | Corporate Officer/Principal | |
| RELMADA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| FUSN PHAR | Pharmaceuticals: Major | Director/Board Member | |
| ALLOVIR, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
PreciseDx Ltd.
 PreciseDx Ltd. Data Processing ServicesTechnology Services PreciseDx Ltd. is a British AI company that specializes in oncology diagnostics. The company is based in Altrincham, UK. The company leverage the analysis of morphology features from histology slides to provide more precise patient-specific risk information. The company's proprietary morphology feature array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making. The company was founded in 2019. Wayne L. Brinster has been the CEO of the company since 2021. | Data Processing Services | Director/Board Member |
Statistics
International
| United States | 41 |
| Canada | 4 |
| United Kingdom | 4 |
| Switzerland | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 12 |
| Finance | 5 |
| Technology Services | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 31 |
| Corporate Officer/Principal | 13 |
| Independent Dir/Board Member | 11 |
| General Counsel | 7 |
| Undergraduate Degree | 7 |
Most connected contacts
| Insiders | |
|---|---|
| Chau Khuong | 38 |
| Michael R. Slater | 9 |
| Molly Harper | 8 |
| Brendan St Amant | 7 |
| Richard Riese | 6 |
| Andrew Marsh | 3 |
| Daniel Rosan | 3 |
- Stock Market
- Insiders
- Jamie Austin
- Company connections
